相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer
Xianzhou Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
VISTA is a checkpoint regulator for naive T cell quiescence and peripheral tolerance
Mohamed A. ElTanbouly et al.
SCIENCE (2020)
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing et al.
IMMUNITY (2019)
Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance
Jinqi Liu et al.
PLOS ONE (2019)
Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation
Eric Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
Katsiaryna Marhelava et al.
CANCERS (2019)
Cyclooxygenase-2 in cancer: A review
Nasser Hashemi Goradel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer
Ping Wu et al.
STRUCTURE (2019)
The Structure of HPK1 Kinase Domain: To Boldly Go Where No Immuno-Oncology Drugs Have Gone Before
Sansana Sawasdikosol et al.
STRUCTURE (2019)
Defining 'T cell exhaustion'
Christian U. Blank et al.
NATURE REVIEWS IMMUNOLOGY (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection
Vishal Khairnar et al.
NATURE COMMUNICATIONS (2018)
Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1/PD-L1 and Other Emerging Checkpoint Pathways
Pottayil G. Sasikumar et al.
BIODRUGS (2018)
Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
Abigail E. Overacre-Delgoffe et al.
CANCER IMMUNOLOGY RESEARCH (2018)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII
Takumi Maruhashi et al.
NATURE IMMUNOLOGY (2018)
The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function
Sairy Hernandez et al.
CELL REPORTS (2018)
Regulatory mechanisms in T cell receptor signalling
Guillaume Gaud et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
William C. Dougall et al.
IMMUNOLOGICAL REVIEWS (2017)
Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins (Review)
Qing Zhang et al.
MOLECULAR MEDICINE REPORTS (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
Nicholas A. Manieri et al.
TRENDS IN IMMUNOLOGY (2017)
CEACAM1 as a multi-purpose target for cancer immunotherapy
Matthew Dankner et al.
ONCOIMMUNOLOGY (2017)
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E. Overacre-Delgoffe et al.
CELL (2017)
The immunobiology of myeloid-derived suppressor cells in cancer
Morteza Motallebnezhad et al.
TUMOR BIOLOGY (2016)
Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators
Hilmar Weinmann
CHEMMEDCHEM (2016)
Immunosuppressive activities of adenosine in cancer
Bertrand Allard et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators
Isabelle Le Mercier et al.
FRONTIERS IN IMMUNOLOGY (2015)
The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw8) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1
Hua Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Hematopoietic progenitor kinase 1 (HPK1) is required for LFA-1-mediated neutrophil recruitment during the acute inflammatory response
Sascha M. Jakob et al.
BLOOD (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Natural killer cell biology: An update and future directions
Kerry S. Campbell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response
Katarzyna Franciszkiewicz et al.
CANCER RESEARCH (2012)
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Andrea Facciabene et al.
CANCER RESEARCH (2012)
HPK1 as a novel target for cancer immunotherapy
Sansana Sawasdikosol et al.
IMMUNOLOGIC RESEARCH (2012)
Down-regulation of B Cell Receptor Signaling by Hematopoietic Progenitor Kinase 1 (HPK1)-mediated Phosphorylation and Ubiquitination of Activated B Cell Linker Protein (BLNK)
Xiaohong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Attenuation of T Cell Receptor Signaling by Serine Phosphorylation-mediated Lysine 30 Ubiquitination of SLP-76 Protein
Xiaohong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death
Laura S. Dickens et al.
MOLECULAR CELL (2012)
Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus
Qing Zhang et al.
JOURNAL OF AUTOIMMUNITY (2011)
Release of serine/threonine-phosphorylated adaptors from signaling microclusters down-regulates T cell activation
Remi Lasserre et al.
JOURNAL OF CELL BIOLOGY (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response
Saba Alzabin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion
Irene M. Patzak et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Regulatory T cells in tumor immunity
Hiroyoshi Nishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
HPK1 Associates with SKAP-HOM to Negatively Regulate Rap1-Mediated B-Lymphocyte Adhesion
Sebastian Koenigsberger et al.
PLOS ONE (2010)
T Cell Activation
Jennifer E. Smith-Garvin et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Proteasome-Mediated Degradation and Functions of Hematopoietic Progenitor Kinase 1 in Pancreatic Cancer
Hua Wang et al.
CANCER RESEARCH (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Hematopoietic Progenitor Kinase 1 Is a Negative Regulator of Dendritic Cell Activation
Saba Alzabin et al.
JOURNAL OF IMMUNOLOGY (2009)
The Adapter Protein SLP-76 Mediates Outside-In Integrin Signaling and Function in T Cells
R. G. Baker et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Death receptor signal transducers: nodes of coordination in immune signaling networks
Nicholas S. Wilson et al.
NATURE IMMUNOLOGY (2009)
Phosphorylation of CARMA1 by HPK1 is critical for NF-κB activation in T cells
Dirk Brenner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Pro-inflammatory prostaglandins and progression of colorectal cancer
Dingzhi Wang et al.
CANCER LETTERS (2008)
Concepts of activated T cell death
Dirk Brenner et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway
Sansana Sawasdikosol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76
Vincenzo Di Bartolo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation
R. Arnold et al.
CELL DEATH AND DIFFERENTIATION (2007)
Cyclooxygenases and lipoxygenases in prostate and breast cancers
Daotai Nie
FRONTIERS IN BIOSCIENCE (2007)
Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses
Jr-Wen Shui et al.
NATURE IMMUNOLOGY (2007)
A distinct inflammatory gene expression profile in patients with psoriatic arthritis
A. K. Stoeckman et al.
GENES AND IMMUNITY (2006)
Tumor-driven evolution of immunosuppressive networks during malignant progression
Ryungsa Kim et al.
CANCER RESEARCH (2006)
Activation or suppression of NFκB by HPK1 determines sensitivity to activation-induced cell death
D Brenner et al.
EMBO JOURNAL (2005)
Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1
R Arnold et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
ADAP-SLP-76 binding differentially regulates supramolecular activation cluster (SMAC) formation relative to T cell-APC conjugation
HY Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival
A Han et al.
IMMUNITY (2003)
Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription
S Sawasdikosol et al.
BLOOD (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes
K Sauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
B cell adaptor containing Src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1
S Tsuji et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling
P Ling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFκB into an inhibitor of NFκB
R Arnold et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung
Y Hosomi et al.
LUNG CANCER (2000)
HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1
J Liou et al.
IMMUNITY (2000)
分享论文
